Central nervous system-selective activity of everolimus

TW202626031APending Publication Date: 2026-07-01MONTARA THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114134805
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-16
Filing Date
2025-09-10
Publication Date
2026-07-01
Patent Text Reader

Abstract

Aspects of the disclosure relate to methods of administering everolimus with peripheral blocker compounds for use in reducing peripheral side effects.
Need to check novelty before this filing date? Find Prior Art